Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAV2 divergent transcript (CAV2-DT, also known as AC002066.1) is a long non-coding RNA gene located on chromosome 7, close to the CAV2 locus[3]. As a lncRNA, it does not encode a protein and is not considered a classic drug target (such as a receptor or enzyme). There are currently no data available about its biological function, disease association, drug interactions, or roles as a biomarker in clinical settings[3]. Its main molecular classification is as a non-protein-coding RNA. No notable issues with the target name or entry were identified. If more information emerges in the scientific literature, especially about its function or disease relevance, this status may change in the future.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CAV2 divergent transcript (CAV2-DT).